课题基金 / 基金详情

An Enzyme Self-Amplification System for Ultrasensitive Detection of Biomarkers at the Point of Care

An Enzyme Self-Amplification System for Ultrasensitive Detection of Biomarkers at the Point of Care
用于在护理点超灵敏检测生物标志物的酶自扩增系统
批准号:
10463564
负责人:
Catherine E. Majors
金额:
$6.5万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-08-01 至 2023-06-30

项目摘要

项目成果

Catherine E. Majors的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY Rapid, inexpensive detection of biomarkers at the point of care is vital for many clinical purposes. However, limitations in current detection platforms have prevented the sensitive detection of many protein and small molecule biomarkers, forcing clinicians to rely either potentially inaccurate empirical diagnosis or expensive lab tests to make critical treatment decisions. Sensitive detection of nucleic acid targets has been readily achieved by exploiting Watson-Crick base pairing to amplify signals (PCR, LAMP, Cas9, etc.), but there has been a lack of innovation for detection of low concentration antigens and small molecules at the point of care. Biology has evolved intricate mechanisms for rapidly amplifying protein signals in vivo via post-translational modification and protein based signaling networks. Towards the goal of developing novel, rapid, ultrasensitive diagnostics, the central hypothesis of this project is that in vitro, protein-based signaling networks incorporating self- amplifying enzymatic pathways will result in biomarker detection platforms with unparalleled sensing capabilities. Specifically, we plan to investigate two mechanisms of protein signaling networks with potential for diagnostics: split enzyme reconstitution and autocatalytic positive feedback loops. First, we will investigate the in vitro use of split adenylate cyclase for small molecule detection. Detection of the analyte will be accomplished by the simultaneously binding two proteins (i.e. a sandwich assay in solution), bringing two halves of adenylate cyclase together and producing cAMP. Second, we will investigate fusions of split adenylate cyclase and cAMP receptor protein to create an autocatalytic feedback loop in vitro. This loop will respond to cAMP by producing more cAMP. Finally, we will develop ordinary differential equation-based models to understand and engineer diagnostic properties. Dynamic models of these protein-signaling networks will be informed by measured experimental parameters. These models will be used to create a combined model for a high sensitivity, fast small molecule sensor as a proof-of-principle for future work. If successful, this system would be broadly applicable for protein and small molecule detection and could be used to detect a wide range of target analytes with known antibody binding domains. As such, this system could be used as a platform for the detection of many protein and small molecule analytes currently unable to be rapidly detected at the point of care. Over the course of the project the fellow will receive technical training in synthetic biology methods, protein engineering, and kinetics computational modeling, in addition to career training in teaching and mentorship best practices, manuscript preparation, grantsmanship, and research communication from the sponsor and co-sponsor and resources available through institutes at Northwestern University. Additionally, the trainee will have the opportunity build a strong professional network of synthetic biologists, diagnostic design experts, and global health clinicians over the course of her training and will continue developing the proposed detection platform into clinically translatable diagnostic devices as an independent researcher.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of a Novel Split Enzyme Diagnostic Platform for Use at the Point of Care
  • 批准号:
    10723565
  • 项目类别:
  • 资助金额:
    $10.79万
  • 财政年份:
    2023
  • 负责人:
    Catherine E. Majors
  • 依托单位:
海外基金